LOCUS BIOSCIENCES INC
- MORRISVILLE, NC 27560-7165
- locus-bio.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM expiring
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $0
- Awards on record
- 2
- Contract vehicles
- 0
- Verified credentials
- 0
SAM.gov registration expires in 50 days
LOCUS BIOSCIENCES INC’s registration expires on Jan 2, 2027. Renewal can take weeks; confirm it stays active through proposal submission and award.
View on SAM.gov (opens in a new tab)Learn more about SAM registration and the UEI
About LOCUS BIOSCIENCES INC
- Headquarters
- MORRISVILLE, NC 27560-7165
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEICJKVLKZGX6F3
- CAGE7H2T2
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $0
- Awards on record
- 2
- Top funding agencies
- n/a
Awards
75N93025C00035
Recompete 18+ mo: Potential end Feb 7, 2029 (26 months away)ADVANCE A NOVEL THERAPEUTIC TO A FIRST-IN-HUMAN CLINICAL STUDY
Department of Health and Human Services · National Institutes of Health
- Obligated
- $13.2M
- Period of performance
- Sep 24, 2025 – Feb 7, 2029
75A50120C00169
Recompete < 6 mo: Potential end Dec 31, 2026 (1 month away)CLINICAL DEVELOPMENT OF CRISPR-CAS3 PHAGE COCKTAIL FOR THE TREATMENT OF RECURRENT URINARY TRACT INFECTIONS CAUSED BY ESCHERICHIA COLI…
Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
- Obligated
- $73.9M
- Period of performance
- Sep 28, 2020 – Dec 31, 2026
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
75N93025C00035 ADVANCE A NOVEL THERAPEUTIC TO A FIRST-IN-HUMAN CLINICAL STUDY | Department of Health and Human Services · National Institutes of Health | 541714 · AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $13.2M | Sep 24, 2025 – Feb 7, 2029 | Recompete 18+ mo: Potential end Feb 7, 2029 (26 months away) |
75A50120C00169 CLINICAL DEVELOPMENT OF CRISPR-CAS3 PHAGE COCKTAIL FOR THE TREATMENT OF RECURRENT URINARY TRACT INFECTIONS CAUSED BY ESCHERICHIA COLI… | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | 541714 · AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | $73.9M | Sep 28, 2020 – Dec 31, 2026 | Recompete < 6 mo: Potential end Dec 31, 2026 (1 month away)AI brief for award 75A50120C00169Bid team for the recompete of award 75A50120C00169 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
Primes it has worked under
- TRUSTEES OF BOSTON UNIVERSITY
UEI THL6A6JLE1S7
$1M
Subcontractor to this prime · 1 sub-award · latest Aug 12, 2024
- Office of Assistant Secretary for Preparedness and Response
- “LOCUS BIOSCIENCES IS A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY DEVELOPING ANTIBACTERIAL THERAPIES USING ENGINEERED BACTERIOPHAGES (CRPHAGE AND DEPOLYMERASE-ENGINEERED), WHICH ARE VIRUSES THAT CAN KILL BACTERIA. THIS PROPOSAL ENABLES THE OPTIMIZATION OF AN ENGINEERED PHAGE COCKTAIL TARGETING K. PNEUMONIAE TO ADVANCE THE PRODUCT TO INITIATE A PHASE 1 CLINICAL TRIAL; A SUBSEQUENT OPTION INCLUDES EXECUTION OF THE CLINICAL TRIAL. THE PROPOSED K. PNEUMONIAE PRODUCT WILL TARGET COMPLICATED URINARY INFECTIONS. LBP-KP01 WILL BE PART OF AN ARSENAL OF COCKTAILS, INCLUDING OUR EXISTING CRPHAGE COCKTAIL TARGETING E. COLI, DESIGNED TO ADDRESS SERIOUS INFECTIONS IRRESPECTIVE OF UNDERLYING DRUG-RESISTANCE WITHIN THE TARGET SPECIES. TOGETHER, THE E. COLI AND K. PNEUMONIAE COCKTAILS HAVE THE POTENTIAL TO TREAT THE MAJORITY OF UTIS.”
Subcontractors it has used
No reported sub-awards as a prime contractor.
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · as of Nov 9, 2026 · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
No SBIR/STTR awards on record
Source: SBIR.gov award records (opens in a new tab) · sync date not recorded
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 541714Research and Development in Biotechnology (except Nanobiotechnology)Primary
SAM.gov does not report this entity as small under any listed NAICS code.
Socio-economic status
No socio-economic certifications reported in SAM.gov.
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with LOCUS BIOSCIENCES INC?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.